123 related articles for article (PubMed ID: 1697132)
1. Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.
Garcia G; Smedile A; Bergmann KF; Gerin JL; Gregory PB; Merigan TC; Robinson WS
West J Med; 1990 Jul; 153(1):80-2. PubMed ID: 1697132
[No Abstract] [Full Text] [Related]
2. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
Transplant Proc; 1993 Feb; 25(1 Pt 2):1446-9. PubMed ID: 7680158
[No Abstract] [Full Text] [Related]
5. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
Thomas HC; Lever AM; Scully LJ; Pignatelli M
Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
[No Abstract] [Full Text] [Related]
6. Delta infection in patients and HBsAg carriers.
Ketiladze ES; Vyazov SO; Chernovetsky MA; Mikhailov MI; Bugayeva NP; Kozlova TP
Prog Clin Biol Res; 1987; 234():461-6. PubMed ID: 3628413
[No Abstract] [Full Text] [Related]
7. Course and prognosis of acute HDV hepatitis.
Caredda F; Antinori S; Re T; Pastecchia C; Moroni M
Prog Clin Biol Res; 1987; 234():267-76. PubMed ID: 3628381
[No Abstract] [Full Text] [Related]
8. Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate.
Esteban R; Buti M; Vallés M; Allende H; Guardia J
Hepatology; 1986; 6(4):762-3. PubMed ID: 2426174
[No Abstract] [Full Text] [Related]
9. Treatment of the chronic hepatitis B virus carrier state.
Lever AM
J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
[TBL] [Abstract][Full Text] [Related]
10. IgM anti-HD in acute hepatitis D: diagnostic and prognostic significance.
Aragona M; Macagno S; Caredda F; Crivelli O; Lavarini C; Bertolusso L; Farci P; Rizzetto M
Prog Clin Biol Res; 1987; 234():243-8. PubMed ID: 3628379
[No Abstract] [Full Text] [Related]
11. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
[TBL] [Abstract][Full Text] [Related]
12. Pathologic and ultrastructural changes of acute and chronic delta hepatitis in an experimentally infected chimpanzee.
Govindarajan S; Fields HA; Humphrey CD; Margolis HS
Am J Pathol; 1986 Feb; 122(2):315-22. PubMed ID: 3511726
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
[TBL] [Abstract][Full Text] [Related]
14. Comparative use of adenine arabinoside and adenine arabinoside monophosphate in varicella and disseminated zoster in immunosuppressed patients.
Vilde JL; Bricaire F; Huchon A; Brun-Vezinet F
J Med Virol; 1983; 12(2):149-53. PubMed ID: 6194253
[TBL] [Abstract][Full Text] [Related]
15. [Delta agent infection and immunoglobulin G in acute HBsAg-positive hepatitis with chronic course].
Tagariello G; Pasquinucci S; Belussi F; Dal Canton A; Alberti A
Boll Ist Sieroter Milan; 1987; 66(6):485-8. PubMed ID: 3453151
[TBL] [Abstract][Full Text] [Related]
16. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
[TBL] [Abstract][Full Text] [Related]
17. [Frequency and clinical relevance of delta virus infection in HBsAg carriers in the Berlin area].
Möller B; Hopf U; Hoffmann H; Alexander M; Lobeck H
Z Gastroenterol; 1988 Jun; 26(6):314-21. PubMed ID: 3264646
[TBL] [Abstract][Full Text] [Related]
18. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
[TBL] [Abstract][Full Text] [Related]
19. Delta hepatitis in Malaysia.
Sinniah M; Dimitrakakis M; Tan DS
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
[TBL] [Abstract][Full Text] [Related]
20. Toxic neuropathy after adenine arabinoside treatment in chronic HBsAg-positive liver disease.
Kanterewicz E; Bruguera M; Viola C; Lamarca J; Rodés J
J Clin Gastroenterol; 1990 Feb; 12(1):90-2. PubMed ID: 1689332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
